Literature DB >> 8442839

Beneficial impact of epidural anesthesia on recovery after outpatient arthroscopy.

S M Parnass1, R J McCarthy, B R Bach, E R Corey, S Hasson, M A Werling, A D Ivankovich.   

Abstract

The ideal outpatient anesthetic provides analgesia, is readily reversible, has minimal complications, and allows for a prompt hospital discharge. Iatrogenic side effects, such as nausea/vomiting and pain, however, may hamper patient recovery and delay discharge. The influence of anesthesia [general (G) versus epidural (E)] was assessed in 260 patients (G = 181, E = 79) undergoing ambulatory knee arthroscopic surgery. Patients were studied before discharge and on follow-up (24 h) to evaluate the effect of the anesthetic technique. Discharge times were shorter in the E group (159 +/- 6 min SEM E, compared with 208 +/- 8 min SEM G), as was the incidence of pain (24.1% versus 49.7%), and nausea/vomiting (8.9% versus 32%) before discharge. Patient satisfaction was equal in the two groups. Our study shows that in select patients, epidural anesthesia is a viable alternative to general anesthesia for knee arthroscopy, offering the advantages of fewer side effects and earlier discharge times.

Entities:  

Mesh:

Year:  1993        PMID: 8442839     DOI: 10.1016/s0749-8063(05)80351-2

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  3 in total

1.  Effects of adding magnesium to bupivacaine and fentanyl for spinal anesthesia in knee arthroscopy.

Authors:  Hüban Dayioğlu; Zehra N Baykara; Asena Salbes; Mine Solak; Kamil Toker
Journal:  J Anesth       Date:  2009-02-22       Impact factor: 2.078

2.  Thoracic epidural anesthesia improves outcome after breast surgery.

Authors:  E P Lynch; K J Welch; J M Carabuena; T J Eberlein
Journal:  Ann Surg       Date:  1995-11       Impact factor: 12.969

3.  A comparison of epidural versus general anesthesia for outpatient endoscopic preperitoneal herniorrhaphy.

Authors:  A L Schuricht; C S McCarthy; W L Wells; R J Kumor; J Cwik
Journal:  JSLS       Date:  1997 Apr-Jun       Impact factor: 2.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.